MWM
EDIT icon

MorganRosel Wealth Management’s Editas Medicine EDIT Stock Holding History

MorganRosel Wealth Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-40
Closed -$88 – 178
2025
Q2 		$88 Hold
40
– – ﹤0.01% 353
2025
Q1 		$46 Buy
+40
New +$59 ﹤0.01% 349

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MorganRosel Wealth Management's EDIT Position: Q3 2025 in Review

MorganRosel Wealth Management sold out of Editas Medicine (EDIT) in Q3 2025, closing a stake of 40 shares — an estimated $88 sold.

MorganRosel Wealth Management first reported a position in EDIT in Q1 2025 and held it in 2 quarters. The position peaked at $88 in Q2 2025. 193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • MorganRosel Wealth Management reported no remaining Editas Medicine position as of Q3 2025 after selling out during the quarter.
  • MorganRosel Wealth Management sold 40 Editas Medicine shares in Q3 2025, an estimated $88.
  • MorganRosel Wealth Management first reported a position in Editas Medicine in Q1 2025 and held it in 2 quarters.
  • MorganRosel Wealth Management's Editas Medicine position peaked at $88 in Q2 2025.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on MorganRosel Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.